The Tisch Cancer Institute
@TischCancer
Followers
4K
Following
2K
Media
2K
Statuses
7K
Committed to cancer prevention, detection, treatment & research. Cancer center for @MountSinaiNYC & @IcahnMountSinai. Appointments: 1-844-MD CANCER
New York, NY
Joined June 2014
Breast lymphoma: Imaging features, clinical presentation, and ultrasou. .@MargoliesLaurie and colleagues @IcahnMountSinai .#breastlymphoma
0
0
2
From @MattGalsky and colleagues in @NatureMedicine:.Adjuvant nivolumab in muscle-invasive urothelial carcinoma: exploratory biomarker analysis of the randomized phase 3 CheckMate 274 trial.
0
0
0
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
528
1K
6K
Jonathan Anker, MD, PhD, has been appointed as Instructor in Hem/Onc. He provides clinical services focused on genitourinary medical oncology and conducts research on tumor immunology and immunotherapy for urothelial cancer. @JonAnker1 @IcahnMountSinai .
1
1
7
Award from @AmericanCancer will fund initiative dedicated to reducing cancer-related health inequities across New York City.
mountsinai.org
0
1
1
Welcome to Stephen Bohlman, MD, PhD! Dr. Bohlman joined Mount Sinai as Assistant Professor of Medicine (Hematology and Medical Oncology). He sees patients with #prostatecancer and #bladdercancer. @IcahnMountSinai
0
0
8
Muscle-Invasive Bladder Cancer: A Watershed Moment | Journal of Clinical Oncology .@MattGalsky @MountsinaiUro @IcahnMountSinai #BladderCancer.
ascopubs.org
The treatment of muscle-invasive bladder cancer (MIBC) has evolved substantially over the past several decades. Muscle-invasive bladder cancer is a disease of older individuals who often have...
0
0
2
Eric Miller, MD, @ericjmiller7 has joined the @IcahnMountSinai Division of Hematology and Medical Oncology faculty as Assistant Professor. Welcome!.
profiles.mountsinai.org
Learn more about Eric Miller, specializing in Cancer (Oncology) at the Mount Sinai Health System. Call or book online for an appointment.
0
0
8
Deubiquitinase-Targeting Chimeras Mediated Stabilization of Tumor Suppressive E3 Ligase Proteins as a Strategy for Cancer Therapy | Journal of the American Chemical Society .Jian Jin, Wenyi Wei, and colleagues.
pubs.acs.org
Targeted protein stabilization has emerged as a promising therapeutic strategy to combat various human diseases linked to aberrant protein degradation. However, the deubiquitinase-targeting chimera...
0
2
2
Molecular Landscape and Therapeutic Strategies of Lung Cancer Lineage . .@fred_hirsch @triparnasen @IcahnMountSinai #lungcancer
0
0
1
New York Giants star advocates for bone marrow donation .@AKeyzner hosts Hudson at @MountSinaiNYC.
pix11.com
NEW YORK (PIX11) – New York Giants Offensive Lineman Bryan Hudson is raising awareness for marrow donors. He has a personal, painful story that now motivates him to make a difference. PIX11’s Moni…
0
1
1
Deaths From Prostate Cancer vs Other Causes: Long-Term Data on NCCN-Based Care.@KAttallaMD @MountsinaiUro weighs in. #prostatecancer.
0
0
0
John Mascarenhas, MD, @IcahnMountSinai, discusses important factors to consider when evaluating patients for clinical trial enrollment in myelofibrosis.via @onclive.
onclive.com
John O. Mascarenhas, MD, discusses important factors to consider when evaluating patients for clinical trial enrollment in myelofibrosis.
0
0
0
The Mount Sinai Hospital is ranked No. 6 in the nation for Cancer by U.S. News & World Report® for 2025-26. .#Cancer #CancerResearch
0
5
12
Three in five liver cancer cases are due to preventable risk factors via @hospitalclinic .Josep Llovet, MD, PhD, @IcahnMountSinai notes that the prevention of #lungcancer is a global priority.
clinicbarcelona.org
Researchers from Clínic-IDIBAPS have participated in a Lancet Commission with international experts highlighting that more than 60% of liver cancer cases could be prevented.
0
0
2
A new Commission outlines evidence-based recommendations for action to reduce the global #HCC burden: @TheLancet .Myron Schwartz, MD, and Josep Llovet, MD, PhD, @IcahnMountSinai are co-authors.
thelancet.com
Liver cancer is the sixth most common cancer and the third leading cause of cancer-related mortality globally. The number of new liver cancers will nearly double, from 0·87 million in 2022 to 1·52...
0
0
0
Twisted Pink Awards $200,000 to Hanna Irie, MD, PhD, @IcahnMountSinai, to Support Metastatic Breast Cancer Research with the help of Conquer Cancer’s EveryGrant .#BreastCancerResearch
6
1
6
RT @OncNewsCentral: After decades of limited results, #CancerVaccines are finally showing robust progress in #Melanoma & #PancreaticCancer—….
oncologynewscentral.com
After decades of disappointment, cancer vaccines have reached a turning point, explains Joshua Brody, MD. He describes what makes today’s vaccines different.
0
3
0